EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Monday reported first-quarter net income of $23.3 million, after reporting a loss in the same period a year earlier.
The Edmonton, Alberta-based company said it had net income of 16 cents per share.
The biotechnology company posted revenue of $62.5 million in the period, which topped Street forecasts. Three analysts surveyed by Zacks expected $60.9 million.
Aurinia shares have fallen 11% since the beginning of the year. The stock has risen 59% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
